ADVFN - ニュース

US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

登録

該当コードがありません。

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/11	05 : 58	Business Wire	血液学/腫瘍学：AOPヘルスの拡大する臨床研究プログラムで新たな結果が判明
2024/06/11	05 : 57	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:RBLX	Roblox Corporation
2024/06/11	05 : 57	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:SRDX	SurModics Inc
2024/06/11	05 : 57	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:CYBR	CyberArk Software Ltd
2024/06/11	05 : 57	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IRWD	Ironwood Pharmaceuticals Inc
2024/06/11	05 : 57	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:INTU	Intuit Inc
2024/06/11	05 : 56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:IT	Gartner Inc
2024/06/11	05 : 56	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:XXXX	Max S&P 500 4x Leveraged ETN due October 30 2043
2024/06/11	05 : 56	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:PRAX	Praxis Precision Medicines Inc
2024/06/11	05 : 56	Business Wire	Tigo Energy soutient les installateurs résidentiels avec un programme de fidélisation présenté à l'Intersolar Europe 2024	NASDAQ:TYGO	Tigo Energy Inc
2024/06/11	05 : 55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NVDA	NVIDIA Corporation
2024/06/11	05 : 55	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:DBX	Dropbox Inc
2024/06/11	05 : 55	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CVGW	Calavo Growers Inc
2024/06/11	05 : 55	Edgar (US Regulatory)	Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses	AMEX:AMJB	Alerian Mlp Index ETNs due January 28 2044
2024/06/11	05 : 55	Edgar (US Regulatory)	Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses	AMEX:AMJB	Alerian Mlp Index ETNs due January 28 2044
2024/06/11	05 : 55	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:AMJB	Alerian Mlp Index ETNs due January 28 2044
2024/06/11	05 : 55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BHFAP	Brighthouse Financial Inc
2024/06/11	05 : 55	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:APDN	Applied DNA Sciences Inc
2024/06/11	05 : 55	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ATAT	Atour Lifestyle Holdings Ltd
2024/06/11	05 : 55	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:AMKR	Amkor Technology Inc
2024/06/11	05 : 55	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:MMYT	MakeMyTrip Limited
2024/06/11	05 : 55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FUSB	First US Bancshares Inc
2024/06/11	05 : 55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:IT	Gartner Inc
2024/06/11	05 : 55	PR Newswire (Canada)	Occupation sans droit de locaux par Québecor Média inc. : l'Assemblée nationale du Québec dépose une demande introductive d'instance pour faire respecter ses droits
2024/06/11	05 : 54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ABOS	Acumen Pharmaceuticals Inc
2024/06/11	05 : 54	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BITF	Bitfarms Ltd
2024/06/11	05 : 54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:NIC	Nicolet Bankshares Inc
2024/06/11	05 : 54	GlobeNewswire Inc.	Le médicament Iqirvo® d’Ipsen obtient l’approbation de la FDA via une procédure accélérée comme traitement PPAR premier de sa classe thérapeutique pour la cholangite biliaire primitive	TG:I7G	Ipsen SA
2024/06/11	05 : 54	GlobeNewswire Inc.	Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis	EU:IPN	Ipsen SA
2024/06/11	05 : 54	GlobeNewswire Inc.	Le médicament Iqirvo® d’Ipsen obtient l’approbation de la FDA via une procédure accélérée comme traitement PPAR premier de sa classe thérapeutique pour la cholangite biliaire primitive	EU:IPN	Ipsen SA

1 2 3 4 5 6 7 8 9 10 次へ >>

American Express

US Dollar vs Sterling

Energy Select Sector SPDR

Health Care Select Sector

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約